Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab
ctDNA profiling may provide a benefit for prediction of survival and progression of HCC patients treated with nivolumab. Future studies are needed for confirmation.
Authors
- Jeffrey S. Morris (ORCID: https://orcid.org/0000-0002-8520-6088)
- Hesham M. Amin (ORCID: https://orcid.org/0000-0002-7973-6699)
- Armeen Mahvash (ORCID: https://orcid.org/0000-0003-0416-4566)
- Tarık Demir (ORCID: https://orcid.org/0000-0001-6334-4079)
- Shadi Chamseddine (ORCID: https://orcid.org/0000-0001-7715-0689)
- Michael LaPelusa (ORCID: https://orcid.org/0000-0001-6078-0561)
- Dan G. Duda (ORCID: https://orcid.org/0000-0001-7065-8797)
- Eugene J. Koay (ORCID: https://orcid.org/0000-0001-7675-3461)
- Robert A. Wolff (ORCID: https://orcid.org/0000-0002-6614-1610)
- James C. Yao (ORCID: https://orcid.org/0000-0002-1875-3962)
- Ahmed Omar Kaseb (ORCID: https://orcid.org/0000-0002-9491-0587)
- Aliya Qayyum (ORCID: https://orcid.org/0000-0003-1590-9041)
- Sunyoung S. Lee (ORCID: https://orcid.org/0000-0002-5954-5991)
- Khaled M. Elsayes (ORCID: https://orcid.org/0000-0003-0184-0717)
- Ahmed Azzam (ORCID: https://orcid.org/0000-0002-1342-5425)
- Lianchun Xiao (ORCID: https://orcid.org/0000-0003-0972-2766)
- Zishuo Ian Hu
- Yehia I. Mohamed (ORCID: https://orcid.org/0000-0002-5192-3804)
- Rikita Hiatia
- Asif Rashid
- Ecaterina E Ileana Dumbrava (ORCID: https://orcid.org/0000-0002-1959-0536)
- Manal M. Hassan (ORCID: https://orcid.org/0000-0002-8413-449X)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- California University of Pennsylvania (US)
- Massachusetts General Hospital (US)
- University of Pennsylvania (US)
- The University of Texas at Austin (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Cancer Biomarkers
- Published
- 2024-09-01
- DOI
- https://doi.org/10.3233/cbm-230431
- Citations
- 9
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- U.S. Department of Defense
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute
- DOD Peer Reviewed Cancer Research Program